Interestingly, bulk and single-cell transcriptomic analysis in brain tissue have found dysregulation of several genes located within the identified 1q21.1 locus, including CHD1L and PRKAB2 transcripts along with several members of the NBPF family of genes, in progressive MS patients compared to control individuals9,24. This evidence concerns the gene CHD1L and myeloid sarcoma.